SESAME technique: septal scoring along the midline endocardium
EuroIntervention · 2025-08 · 21 (16) · 942-951
DOI: 10.4244/eij-d-25-00131 ↗Kurz gefasst
Fachartikel in der Zeitschrift EuroIntervention, 2025-08. Verfasst von James M McCabe und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, University of Washington School of Medicine, Seattle, WA, USA. Hauptthemen laut MEDLINE: Cardiomyopathy, Hypertrophic, Endocardium, Cardiac Catheterization, Heart Septum. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 13 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
BACKGROUND: The management of interventricular septal hypertrophy is an area of rapidly increasing interest, spurred by continued challenges with transcatheter mitral valve replacement (TMVR) and the management of obstructive hypertrophic cardiomyopathy (oHCM). AIMS: We sought to evaluate the reproducibility of septal scoring along the midline endocardium (SESAME), a novel transcatheter intervention designed to replicate surgical myotomy. METHODS: This single-centre, retrospective review included all patients who underwent the SESAME procedure at the University of Washington from January 2022 to September 2024. RESULTS: A total of 54 consecutive patients underwent SESAME at our institution: 47 prior to TMVR, 6 for oHCM, and 1 for a subaortic membrane. Technical success was achieved in 100% of patients. In pre-TMVR patients, the median neo-left ventricular outflow tract (LVOT) and the median skirt neo-LVOT areas gained were 146 (first quartile [Q1]: 76.5, third quartile [Q3]: 286.3) mm2 and 54 (Q1: 32.8, Q3: 100.2) mm2, respectively. In the oHCM population, invasive resting and provocable LVOT gradients immediately decreased from 59 (Q1: 32, Q3: 99) mmHg to 10 (Q1: 5, Q3: 19) mmHg and from 121 (Q1: 53, Q3: 205) mmHg to 34 (Q1: 16, Q3: 56) mmHg, respectively. The median echo gradients decreased from 62 (Q1: 53, Q3: 64) mmHg at baseline to 6 (Q1: 6, Q3: 8) mmHg at 30 days. Among the pre-TMVR population, there were 2 procedural deaths from free-wall rupture early in the experience and 3 restrictive ventricular septal defects that did not require intervention. Three patients (5.5%) required a pacemaker. Procedural complications significantly decreased after the first 10 cases in 2022 (p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Cardiology, University of Washington School of Medicine, Seattle, WA, USA.
- Department of Anesthesiology & Pain Medicine, University of Washington School of Medicine, Seattle, WA, USA.
- Department of Cardiology, Naval Medical Center, San Diego, CA, USA.
- Structural Heart and Valve Center, Emory University Hospital, Atlanta, GA, USA.
- Division of Intramural Research, National Heart Lung and Blood Institute, NIH, Bethesda, MD, USA.
Zitieren
APA
McCabe, J. M., Newton, S., Danek, B. A., Elison, D., Chung, C. J., Sheu, R., Jelacic, S., Condos, G. J., Canovas, E., Greenbaum, A. B., Babaliaros, V. C., Lederman, R. J., & Mackensen, G. B. (2025). SESAME technique: septal scoring along the midline endocardium. EuroIntervention, 21(16), 942-951. https://doi.org/10.4244/eij-d-25-00131
Vancouver
McCabe JM, Newton S, Danek BA, Elison D, Chung CJ, Sheu R, et al. SESAME technique: septal scoring along the midline endocardium. EuroIntervention. 2025;21(16):942-951. doi:10.4244/eij-d-25-00131
BibTeX
@article{McCabe2025,
author = {McCabe, James M and Newton, Shauna and Danek, Barbara A and Elison, David and Chung, Christine J and Sheu, Richard and Jelacic, Srdjan and Condos, Gregory J and Canovas, Ester and Greenbaum, Adam B and Babaliaros, Vasilis C and Lederman, Robert J and Mackensen, G Burkhard},
title = {SESAME technique: septal scoring along the midline endocardium},
journal = {EuroIntervention},
year = {2025},
volume = {21},
number = {16},
pages = {942--951},
doi = {10.4244/eij-d-25-00131}
}
EUVIMED